{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:17:10Z","timestamp":1787847430233,"version":"build-2784847793"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Type 1 diabetes mellitus (T1DM) is an autoimmune disorder caused by pancreatic \u03b2-cells destruction. Anti-pancreatic antibodies are the witness of \u03b2-cell destruction and their dosage is mainly used for etiological diagnosis. Patients with T1DM are at increased risk of developing other autoimmune reactions, which may involve other organs, resulting in organ specific autoimmune disease. The most frequently encountered are autoimmune thyroid disease, followed by celiac and gastric disease and other rare autoimmune diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The purpose of this study is to investigate the prevalence of autoimmune markers in patients with T1DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study was conducted at the Department of Endocrinology of the Military Hospital Moulay Ismail in Meknes Morocco, from January 2016 to December 2018. All Type 1 diabetes patients consulting during the study period were included in the study. Their clinical and biochemical data were collected at their first presentation, made up of anti-pancreatic antibodies (glutamic acid decarboxylase [GAD] antibody, tyrosine phosphatase antibody, and islet cell antibody) and other organ-specific antibodies: the thyroid (antithyroid peroxidase antibody, antithyroglobulin antibody, and antithyroid-stimulating hormone receptor antibody), the intestine (IgA antitissue transglutaminase antibody), the adrenal gland (anti-21 hydroxylase antibody), and the stomach (antigastric parietal cell antibody and anti-intrinsic factor antibody).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fifty-four patients were included, with an average age of 26 years. GAD, tyrosine phosphatase, and islet cell antibodies were detected in 74%, 22%, and 3.7%, respectively, of the 54 patients examined. The prevalence of extrapancreatic autoimmunity was 45% with a large preponderance among different immunities of those from thyroid and celiac diseases (CDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our results confirm that patients with Type 1 diabetes should be investigated for the presence of autoimmune diseases mainly from thyroid and CDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_8_20","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T06:43:45Z","timestamp":1624085025000},"page":"19-23","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["The Profile of Autoimmunity in Type 1 Diabetes Patients"],"prefix":"10.4103","volume":"20","author":[{"given":"Sara","family":"Derrou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay\u00e7al","family":"El Guendouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousra","family":"Benabdelfedil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Chakri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Ouleghzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaya","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20240831","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12021","article-title":"Pathogenesis of type 1 diabetes: Lessons from natural history studies of high-risk individuals","volume":"1281","author":"Nokoff","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"R3-4-20240831","first-page":"49","article-title":"Pancreas-specific autoimmune markers in clinical practice","volume":"17","author":"Leroy","year":"2013","journal-title":"Correspondances en M\u00e9tabolismes Hormones Diab\u00e8tes Nutr"},{"key":"R4-4-20240831","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.1016\/j.lpm.2012.10.003","article-title":"Pancreatic islet autoimmunity","volume":"41","author":"Boitard","year":"2012","journal-title":"Presse Med"},{"key":"R5-4-20240831","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2009.02.019","article-title":"Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus","volume":"8","author":"Tsirogianni","year":"2009","journal-title":"Autoimmun Rev"},{"key":"R6-4-20240831","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1373\/clinchem.2010.148205","article-title":"Autoimmune markers in diabetes","volume":"57","author":"Winter","year":"2011","journal-title":"Clin Chem"},{"key":"R7-4-20240831","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/2230-8210.179994","article-title":"Association of type 1 diabetes mellitus and autoimmune disorders in Brazilian children and adolescents","volume":"20","author":"Alves","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"R8-4-20240831","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4239\/wjd.v5.i4.505","article-title":"Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus","volume":"5","author":"Pipi","year":"2014","journal-title":"World J Diabetes"},{"key":"R9-4-20240831","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1038\/366069a0","article-title":"Spontaneous loss of T-cell tolerance of glutamine acid decarboxylase in murine insulin-dependent diabetes","volume":"366","author":"Kaufman","year":"1993","journal-title":"Nature"},{"key":"R10-4-20240831","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/366072a0","article-title":"Immune response to glutamic acid decarboxylase toleranve correlates with insulinitis in non-obese diabetic mice","volume":"366","author":"Tisch","year":"1993","journal-title":"Nature"},{"key":"R11-4-20240831","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2015.05.002","article-title":"Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM)","volume":"14","author":"Kakleas","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R12-4-20240831","first-page":"406","article-title":"Type 1 diabetes and autoimmunity","volume":"74","author":"Graja","year":"2013","journal-title":"Ann d'Endocrinol"},{"key":"R13-4-20240831","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.dsx.2012.08.006","article-title":"Clinical profile of coexisting conditions in type 1 diabetesmellitus patients","volume":"6","author":"Kota","year":"2012","journal-title":"Diabetes Metab Syndrome Clin Res Rev"},{"key":"R14-4-20240831","doi-asserted-by":"crossref","first-page":"439463","DOI":"10.4061\/2011\/439463","article-title":"Thyroid disorders and diabetes mellitus","volume":"2011","author":"Hage","year":"2011","journal-title":"J Thyroid Res"},{"key":"R15-4-20240831","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1297\/cpe.23.99","article-title":"Type 1 diabetes and autoimmunity, department of diabetes and metabolisme, Nagasaki harbor medical center city hospital, Nagasaki Japon","volume":"23","author":"Kawasaki","year":"2014","journal-title":"Clin Pediate Endocrinol"},{"key":"R16-4-20240831","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated autoimmunity","volume":"15","author":"Kahaly","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R17-4-20240831","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-8227(00)81787-8","article-title":"Autoimmune thyroid disease in type 1 diabetes mellitus","volume":"50","author":"Porandalaa","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"R18-4-20240831","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/dc10-1756","article-title":"Additional autoimmune disease found in 33% of patients at type 1 Diabetes Onset","volume":"34","author":"Taylor","year":"2011","journal-title":"Diabetes Care"},{"key":"R19-4-20240831","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.humimm.2004.02.026","article-title":"Analysis of HLA genes in families with autoimmune diabetes and thyroiditis","volume":"65","author":"Levin","year":"2004","journal-title":"Hum Immunol"},{"key":"R20-4-20240831","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/diacare.25.8.1346","article-title":"Thyroid autoimmunity in children and adolescents with type 1 diabetes: A multicenter survey","volume":"25","author":"Kordonouri","year":"2002","journal-title":"Diabetes Care"},{"key":"R21-4-20240831","first-page":"113","article-title":"Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type","volume":"52","author":"Holl","year":"1999","journal-title":"Horm Res"},{"key":"R22-4-20240831","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0950-3579(05)80241-9","article-title":"Sex hormones and the immune system--Part 2.Animal data","volume":"4","author":"Ahmed","year":"1990","journal-title":"Baillieres Clin Rheumatol"},{"key":"R23-4-20240831","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/art.1780210719","article-title":"Autoimmunity and the immunological network","volume":"21","author":"Talal","year":"1978","journal-title":"Arthritis Rheum"},{"key":"R24-4-20240831","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00281-012-0313-0","article-title":"Celiac disease in children and adolescents: Special considerations","volume":"34","author":"Newton","year":"2012","journal-title":"Semin Immunopathol"},{"key":"R25-4-20240831","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMra030158","article-title":"Autoimmune polyendocrine syndromes","volume":"350","author":"Eisenbarth","year":"2004","journal-title":"N Engl J Med"},{"key":"R26-4-20240831","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ecl.2003.12.007","article-title":"Celiac disease associated with type 1 diabetes mellitus","volume":"33","author":"Rewers","year":"2004","journal-title":"Endocrinol Metab Clin N Am"},{"key":"R27-4-20240831","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2337\/dc11-2171","article-title":"IgA anti-transglutaminase autoantibodies at type 1 diabetes onset are less frequent in adult patients and are associated with a general celiac-specific lower immune response in comparison with nondiabetic celiac patients at diagnosis","volume":"35","author":"Tiberti","year":"2012","journal-title":"Diabetes Care"},{"key":"R28-4-20240831","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1440-1746.2010.06508.x","article-title":"Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in north India","volume":"26","author":"Bhadada","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R29-4-20240831","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1442-200X.2010.03085.x","article-title":"Celiac disease prevalence in children and adolescents with type 1 diabetes from Serbia","volume":"52","author":"Djuri\u0107","year":"2010","journal-title":"Pediatr Int"},{"key":"R30-4-20240831","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1053\/j.gastro.2005.02.030","article-title":"Epidemiology of celiac disease: What are the prevalence, incidence, and progression of celiac disease?","volume":"128","author":"Rewers","year":"2005","journal-title":"Gastroenterology"},{"key":"R31-4-20240831","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/pgmj.75.886.467","article-title":"Clinical presentation of thyroid dysfunction and Addison's disease in young adults with type 1 diabetes","volume":"75","author":"Leong","year":"1999","journal-title":"Postgrad Med J"},{"key":"R32-4-20240831","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1464-5491.1994.tb02018.x","article-title":"Prevalence of islet cell and thyrogastric autoantibodies in Sudanese patients with type 1 diabetes","volume":"11","author":"Magzoub","year":"1994","journal-title":"Diabet Med"},{"key":"R33-4-20240831","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3476(82)80227-8","article-title":"Organ-specific autoantibodies in children with common endocrine diseases","volume":"100","author":"Bright","year":"1982","journal-title":"J Pediatr"},{"key":"R34-4-20240831","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2010.40","article-title":"Autoimmune polyglandular syndromes","volume":"6","author":"Michels","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"R35-4-20240831","first-page":"201","article-title":"Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM)","volume":"71","author":"Karavanaki","year":"2009","journal-title":"Horm Res"},{"key":"R36-4-20240831","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2249.2001.01668.x","article-title":"Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes","volume":"126","author":"De Block","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"R37-4-20240831","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1651-2227.1982.tb09403.x","article-title":"Organ-specific antibodies in healthy and diabetic children and young adults","volume":"71","author":"Kokkonen","year":"1982","journal-title":"Acta Paediatr Scand"},{"key":"R38-4-20240831","first-page":"4062","article-title":"High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry","volume":"84","author":"De Block","year":"1999","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_8_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:17:55Z","timestamp":1787843875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_8_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_8_20","relation":{},"ISSN":["1596-3519"],"issn-type":[{"value":"1596-3519","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}